A kind of lung cancer marker anti-hmgb3 autoantibody and its application
One-HMGB3, autoantibody technology, applied in the field of lung cancer marker anti-HMGB3 autoantibody, can solve the problem of unsatisfactory tumor markers
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] 1. Serum Specimen Collection
[0030] In the test stage of the present invention, 184 lung cancer patients and 184 normal human sera were used in total to conduct preliminary evaluation of anti-HMGB3 autoantibodies in the diagnosis of lung cancer; in the verification stage, 446 lung cancer patients, 446 normal people and 119 benign lung diseases were used. Patient sera were subjected to further evaluation of anti-HMGB3 autoantibodies in the detection of lung cancer. All lung cancer patients were pathologically diagnosed as lung cancer, normal subjects came from routine physical examination population, and all non-cancer subjects were confirmed to be free from tumor-related diseases and autoimmune diseases. The blood samples were centrifuged at 3500 rpm for 5 minutes, the serum was aliquoted and labeled, and stored in a -80°C refrigerator for later use.
[0031] . Screening of Oncomine database
[0032] The invention excavates and screens the relevant information of l...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com